MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
15.42
+0.28
+1.85%
After Hours: 15.42 0 0.00% 16:10 04/02 EDT
OPEN
14.85
PREV CLOSE
15.14
HIGH
15.60
LOW
14.85
VOLUME
36.06K
TURNOVER
--
52 WEEK HIGH
19.50
52 WEEK LOW
11.51
MARKET CAP
2.69B
P/E (TTM)
5.89
1D
5D
1M
3M
1Y
5Y
1D
HUTCHMED files Form 3 for Group General Counsel Charles George Rupert Nixon
Reuters · 3d ago
Orient Securities Remains a Buy on HUTCHMED (China) (HCM)
TipRanks · 4d ago
Weekly Report: what happened at HCM last week (0323-0327)?
Weekly Report · 5d ago
Hutchmed Expands Oncology Pipeline With New First‑in‑Human Solid Tumor Trial
TipRanks · 03/27 16:36
HUTCHMED (China) (HCM) Gets a Buy from GF Securities
TipRanks · 03/24 07:05
Weekly Report: what happened at HCM last week (0316-0320)?
Weekly Report · 03/23 10:06
HUTCHMED Initiates And Doses First Patient In Phase III Trial Of HMPL-760 For R/R DLBC Lymphoma
NASDAQ · 03/23 08:28
HUTCHMED starts China Phase 3 trial of HMPL-760 plus R-GemOx in relapsed or refractory DLBCL
Reuters · 03/23 00:01
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.